ADIPOQ and Insulin resistance: Here, the results demonstrate that in WT mice, treatment with adiponectin-expressing tTreg precursors significantly attenuates HFD-induced metabolic abnormalities, including systemic insulin resistance, fatty liver injuries, and adipose tissue inflammation.